The Journal of Physiology
Adaptations of glucagon-like peptide-1 receptor agonist-induced weight loss, drivers of weight regain and future directions of therapeutics
ReviewInterventions
Related
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
JCI Insight6 Oct 2026
Antibody reduced fat while preserving lean mass in mice
